BRIEF-U.S. FDA says continues to find benefits of flumist quadrivalent outweigh any potential risks By: Reuters: Company News June 28, 2016 at 13:57 PM EDT * FDA continues to find that the benefits of flumist quadrivalent outweigh any potential risks Read More >> Related Stocks: Astrazeneca Plc ADR